Nurix Therapeutics’ Christine Ring sells 3,957 shares
The reported share sale funded tax withholding tied to RSU vesting and was required under Nurix’s equity incentive plans, rather than discretionary.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics, Inc. Chief Legal Officer Christine Ring reported vesting 10,182 restricted stock units and acquiring the corresponding common shares on October 30, 2026. She also reported selling 3,957 shares at a weighted average price of $26.2791 per share.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
7 txns
Insider
Ring Christine
Role
Chief Legal Officer
Sold
3,957 shs ($104K)
Approx. gross sale proceeds
$104K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F3, F4, F5 | 3,750 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F3, F6, F5 | 2,859 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F3, F7, F5 | 3,573 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,750 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,859 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,573 | $0.00 | $0.00 |
| Sale | Common Stock F1, F2 | 3,957 | $26.2791 | $104K |
Holdings After Transaction:
Restricted Stock Units — 60,380 contracts (Direct);
Common Stock — 15,335 shares (Direct)
Footnotes (7)
- F1. The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- F2. Represents the weighted average sale price. The lowest price at which shares were sold was $26.135 and the highest price at which shares were sold was $26.42. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
- F3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F4. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2024, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- F5. RSUs do not expire; they either vest or are canceled prior to the vest date.
- F6. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2025, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
- F7. The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2026, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
Key Figures
RSUs converted to common stock: 10,182 shares
Common shares sold: 3,957 shares
Weighted average sale price: $26.2791 per share
+2 more
5 metrics
RSUs converted to common stock
10,182 shares
Three transactions on October 30, 2026
Common shares sold
3,957 shares
October 30, 2026
Weighted average sale price
$26.2791 per share
October 30, 2026
Lowest reported sale price
$26.135 per share
Shares sold on October 30, 2026
Highest reported sale price
$26.42 per share
Shares sold on October 30, 2026
Key Terms
restricted stock unit, sell to cover, weighted average sale price
3 terms
restricted stock unit financial
"contingent right to receive one share of the Issuer's common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
sell to cover financial
"funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
weighted average sale price financial
"Represents the weighted average sale price"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the vesting schedule for Christine Ring’s NRIX restricted stock units?
Each of the three RSU awards vests in quarterly increments of 1/12 of the total award over three years, subject to Christine Ring providing services on each vesting date. The first quarterly increments were scheduled for July 30, 2024, July 30, 2025, and July 30, 2026, respectively.
AI-generated analysis. How Rhea-AI works. Not financial advice.
